InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: GuTA post# 113727

Tuesday, 07/28/2015 7:30:02 PM

Tuesday, July 28, 2015 7:30:02 PM

Post# of 403755
Lets see:
Kevetrin phase 1 wrapping up... with restoration mdm2 pathway and p53. Disappearing spleen lesion, stable stage 4 ovarian cancer orphan drug status. Starting ovarian cancer p2/3, phase 2 in solid tumors and a phase 2 AML (someone else paying). Trial at Harvard. Platform drug

Brilacidin ABSSSI phase 2b results one day treatment equivalent 7 days of the gold-standard billionaire drug Daptomycin. Novel antibiotic that rips the plasma membrane of the bacteria so resistance is futile. QIPD'd a platform drug with anti-inflammatory properties.

Brilacidin-OM currently no effective treatments. Phase 2 underway with expanded trial sites. Brilacidin vs placebo like a Sharknado Nuff Said.

Prurisol- I don't care =-) But phase 2 start or started. Oral psoriasis drug huge market potential.

And a big fat pipeline

Sad attempts at manipulation because you realized stocks go up and down don't belong on this list.